FIELD: medicine.
SUBSTANCE: decreased thrombocyte activity in patients suffering from metabolic syndrome is ensured within 2-3 months with complex therapy including individually prescribed hypo-calorie diet, calculated by formula considering age and sex of the patient and combined with introduction of Amlodipine dosed 5 mg once in the morning, Lisinopril dosed 5 mg once in the morning and Atorvastatine dosed 30 mg once in the evening.
EFFECT: extended range of methods for effective correction of thrombocyte haemostasis in MS patients, reduced thrombotic complications due to optimal combination of nonmedicamentous therapy and specific medical products introduced in doses specified above during empirically defined course of treatment.
2 ex
